Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement
Journal of the National Comprehensive Cancer Network · 2026-05 · 24 (5)
DOI: 10.6004/jnccn.2025.7105 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-05. Verfasst von Christopher R D'Angelo und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE. Hauptthemen laut MEDLINE: Multiple Myeloma, Central Nervous System Neoplasms. Die Arbeit nennt 148 Literaturangaben.
Abstract (Originalsprache)
Extramedullary presentations of multiple myeloma (MM) involving the central nervous system (CNS) carry a dismal prognosis. Although historically rare, management of extramedullary disease—including CNS manifestations—has become increasingly clinically relevant as advances in systemic therapies have prolonged control of medullary disease. CNS manifestations may occur across a variety of clinical settings and at different time points throughout the disease course. Common symptoms include visual changes, headaches, loss of sensation, confusion, and seizures. MRI identifies leptomeningeal enhancement and/or parenchymal lesions in approximately 90% of cases, and lumbar puncture with cerebrospinal fluid testing for clonal plasma cell populations is confirmatory. Encouragingly, the incorporation of novel therapeutic agents has improved historically poor outcomes in CNS MM. Novel immunotherapeutic approaches using CAR T-cell therapy and bispecific T-cell–engaging antibodies have recently demonstrated significant efficacy in consolidating responses. Multimodality treatment strategies incorporating intrathecal chemotherapy, systemic novel agents, radiation therapy, and immunotherapy hold promise for achieving more durable responses in this devastating manifestation of MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE.
- 2Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL.
- 3The Ohio State University Comprehensive Cancer Center, Columbus, OH.
- 4Huntsman Cancer Institute University of Utah, Salt Lake City, UT.
- 5Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
- 6Yale University Cancer Center, New Haven, CT.
Zitieren
APA
D'Angelo, C. R., Derman, B. A., Devarakonda, S., Godara, A., Lee, H. C., Robinson, T., Kumar, S., & Callander, N. (2026). Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement. Journal of the National Comprehensive Cancer Network, 24(5). https://doi.org/10.6004/jnccn.2025.7105
Vancouver
D'Angelo CR, Derman BA, Devarakonda S, Godara A, Lee HC, Robinson T, et al. Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement. Journal of the National Comprehensive Cancer Network. 2026;24(5). doi:10.6004/jnccn.2025.7105
BibTeX
@article{DAngelo2026,
author = {D'Angelo, Christopher R and Derman, Benjamin A and Devarakonda, Srinivas and Godara, Amandeep and Lee, Hans C and Robinson, Timothy and Kumar, Shaji and Callander, Natalie},
title = {Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {5},
doi = {10.6004/jnccn.2025.7105}
}
EUVIMED